Last update 07 Jun 2025

VEGF activator zinc finger protein(Sangamo Therapeutics)

Overview

Basic Info

Drug Type
Gene therapy
Synonyms
hVEGF-A, SB 509, SB-509
Target
Action
stimulants, inducers
Mechanism
VEGF-A stimulants(Vascular endothelial growth factor A stimulants), Angiogenesis inducers, Gene transference(Gene transference)
Active Indication-
Originator Organization
Active Organization-
License Organization-
Drug Highest PhaseDiscontinuedPhase 3
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Macular EdemaPhase 3
United States
01 Jul 2009
Macular EdemaPhase 3
Canada
01 Jul 2009
Macular EdemaPhase 3
Colombia
01 Jul 2009
Macular EdemaPhase 3
India
01 Jul 2009
Macular EdemaPhase 3
Israel
01 Jul 2009
Amyotrophic Lateral SclerosisPhase 2
United States
01 Sep 2008
Diabetes Mellitus, Type 1Phase 2
United States
01 Nov 2006
Diabetes Mellitus, Type 1Phase 2
Mexico
01 Nov 2006
Diabetes Mellitus, Type 2Phase 2
United States
01 Nov 2006
Diabetes Mellitus, Type 2Phase 2
Mexico
01 Nov 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free